September 2011

September 28, 2011
VALEANT PHARMACEUTICALS ANNOUNCES APPROVAL OF COLESEVELAM HYDROCHLORIDE IN CANADA

July 2011

July 25, 2011
VALEANT PHARMACEUTICALS ANNOUNCES APPROVAL OF SUBLINOX® IN CANADA

July 2011

July 11, 2010
VALEANT PHARMACEUTICALS AGREES TO ACQUIRE DERMIK

June 2011

June 6, 2011
VALEANT PHARMACEUTICALS ANNOUNCES LICENSE AGREEMENT WITH MEDA FOR NORTH AMERICAN RIGHTS FOR ELIDEL® AND XERESE™

April 2011

April 07, 2011
MEDA TO LICENSE ELIDEL TO VALEANT PHARMACEUTICALS

February 2011

February 10, 2010
VALEANT PHARMACEUTICALS ANNOUNCES ACQUISITION OF CHOLESTAGEL® IN CANADA

February 2010

February 8, 2010
VALEANT PHARMACEUTICALS ANNOUNCES LICENSE OF ACZONE® (dapsone) Gel 5%IN CANADA

February 2010

February 03, 2010
VVALEANT PHARMACEUTICALS TO ACQUIRE U.S. AND CANADIAN RIGHTS TO ZOVIRAX®

June 2010

June 21, 2010
Valeant and Biovail Agree to Merge

May 2010

May 10, 2010

Valeant Pharmaceuticals Announces Regulatory Approval
of  ^NOnsolis™  in Canada

December 2009

December 8, 2009
Valeant Canada to Acquire Laboratoire Dr. Renaud in Canada

May 2009

May 22, 2009
Valeant Canada Wins Four Awards, Including Company of the Year at the Chamber of Commerce of St-Laurent.

January 2009

January 1, 2009
Valeant Canada Limited Becomes the Canadian Distributor of ^T/CDiastat® (Diazepam) in Replacement of Shire Canada Inc.

July 2007

July 30, 2007
Valeant Pharmaceuticals Begins Distribution of ^CXyrem® in Canada

January 2007

January 12, 2007
Valeant Pharmaceuticals Signs Licensing Agreement for Canadian Rights to ^CXyrem® (Sodium Oxybate) from Jazz Pharmaceuticals

This site is for residents of Canada

© Valeant Pharmaceuticals International, Inc. 2010